Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data].
Ferraro PM, D'Ovidio V, Bresci G, Astegiano M, Principi B, D'Inca' R, Testa R, Valpiani D, Guidi L, Armuzzi A, Costa F, Aratari A, Vecchi M, De Franchis R, Di Leo V, Ricci C, Riegler G, Colombo E, Repaci G, Lecis P, Silla M, Passalacqua S. Ferraro PM, et al. Among authors: passalacqua s. G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S144-6. G Ital Nefrol. 2012. PMID: 22388848 Italian.
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
Passalacqua S, Ferraro PM, Bresci G, D'Ovidio V, Astegiano M, Principi M, Testa R, D'Incà R, Valpiani D, Armuzzi A, Sablich R, Cavallaro F, Costa F, Di Leo V, Colombo E, Santini A, Aratari A, Lecis P, Saladino V, Riegler G, Marco M, Calella F, Ricci C, Guidi ML, Repaci G, Silla M. Passalacqua S, et al. J Clin Apher. 2011 Dec;26(6):332-7. doi: 10.1002/jca.20315. Epub 2011 Nov 9. J Clin Apher. 2011. PMID: 22072543
Reduced incidence of cardiovascular events in hyper-Lp(a) patients on lipoprotein apheresis. The G.I.L.A. (Gruppo Interdisciplinare Aferesi Lipoproteica) pilot study.
Bigazzi F, Sbrana F, Berretti D, Maria Grazia Z, Zambon S, Fabris A, Fonda M, Vigna GB, D'Alessandri G, Passalacqua S, Dal Pino B, Pianelli M, Luciani R, Ripoli A, Rafanelli D, Manzato E, Cattin L, Sampietro T. Bigazzi F, et al. Among authors: passalacqua s. Transfus Apher Sci. 2018 Oct;57(5):661-664. doi: 10.1016/j.transci.2018.07.015. Epub 2018 Aug 1. Transfus Apher Sci. 2018. PMID: 30087087
Semi-selective immunoadsorption treatment in myasthenia gravis.
Splendiani G, Passalacqua S, Barbera G, Sturniolo G, Costanzi S, Fulignati P, Casciani CU. Splendiani G, et al. Among authors: passalacqua s. Biomater Artif Cells Immobilization Biotechnol. 1992;20(5):1145-51. doi: 10.3109/10731199209117341. Biomater Artif Cells Immobilization Biotechnol. 1992. PMID: 1457688 Clinical Trial.
Myasthenia gravis (MG) treatment with immunoadsorbent columns.
Splendiani G, Passalacqua S, Barbera G, Sturniolo A, Costanzi S, Bartoccioni E, Casciani CU. Splendiani G, et al. Among authors: passalacqua s. Biomater Artif Cells Immobilization Biotechnol. 1991;19(1):255-65. doi: 10.3109/10731199109117831. Biomater Artif Cells Immobilization Biotechnol. 1991. PMID: 1751675
38 results